We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA wants centralized institutional review boards (IRBs) to coordinate the actions of multiple IRBs in multicenter clinical research, according to new industry guidance.